Food and Drug Administration | Drug Enforcement Administration | drug | Food and Drug Administration (United States) | Illegal drug trade | cannabis (drug) | Recreational drug use | Shoppers Drug Mart | Psychoactive drug | National Institute on Drug Abuse | Drug rehabilitation | Drug Abuse Resistance Education | Cannabis (drug) | Pure Food and Drug Act | Drug withdrawal | drug lord | psychoactive drug | Pharmaceutical drug | pharmaceutical drug | Federal Food, Drug, and Cosmetic Act | Drug Wars: The Camarena Story | Drug | Antiviral drug | recreational drug use | National Drug Intelligence Center | National Council on Alcoholism and Drug Dependence | Mexican Drug War | Illegal drug trade in Colombia | illegal drug trade | Drug test |
Lebrikizumab (INN) is a humanized monoclonal antibody and an experimental immunosuppresive drug for the treatment of asthma that cannot be adequately controlled with inhalable glucocorticoids.